SFTS survivors in the high viral load group (HVL) exhibited significantly higher incidences of alopecia, arthralgia, memory impairment, and visual impairment; as well as more frequent laboratory abnormalities, including elevated level of ALT, AST, GGT, decreased level of LYM%, NEUT%, UA, and WBC, compared to the LVL group (all P < 0.05) (Fig 2). Here, GPT is linked to alopecia.